Daniela Berheide News Today

Venlo, the Netherlands, April 03, 2024 -- QIAGEN N.V. today announced a series of new products to further enhance cancer research as well as to enable urine collection and stabilization as a new...

Venlo, the Netherlands, March 25, 2024 -- QIAGEN today announced the release of the QIAstat-Dx Analyzer 2.0, including the Software 1.6 upgrade, a significant enhancement to the widely-used...

Venlo, the Netherlands, and Redwood City, California, Feb. 27, 2024 -- QIAGEN today announced the launch of QIAGEN Biomedical KB-AI, a new generative AI-driven knowledge base designed to propel...

Venlo, the Netherlands, Feb. 15, 2024 -- QIAGEN today announced two significant achievements in sustainability through recognitions by My Green Lab, a non-profit organization dedicated to...

Germantown, Maryland, and Venlo, the Netherlands, Jan. 08, 2024 -- QIAGEN today announced the U.S. Food and Drug Administration clearance for the NeuMoDx CT/NG Assay 2.0, growing its test menu...

Venlo, the Netherlands, Jan. 07, 2024 -- QIAGEN N.V. today announced a plan to return up to approximately $300 million to shareholders through a synthetic share repurchase that combines a direct...

Venlo, the Netherlands, Nov. 09, 2023 -- QIAGEN today announced the launch of three new kits for use on its QIAcuity systems and a major new software update designed to expand the portfolio of...

Simplified and accelerated research workflow including high-quality DNA extraction kits, library preparation for whole genome metagenomics, and user-friendly bioinformatics analysis // Workflow enables diverse microbiome research applications, including gut health, soil microbiology, and antibiotic resistance, maximizing DNA diversity and minimizing bias // Expanding growing portfolio of QIAGEN microbiome solutions, covering every aspect of the scientific workflowVenlo, the Netherlands, Nov. 06,

Document UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ...

Venlo, the Netherlands, Oct. 30, 2023 -- QIAGEN announced results for the third quarter and first nine months of 2023. Net sales results of $470 million at constant exchange rates for Q3 2023...